INTRODUCTION
Insulin and glucocorticoids are potent metabolic hormones that have opposite effects in hepatic carbohydrate metabolism. Glycolysis is induced by high concentrations of insulin and low concentrations of glucocorticoids ; conversely, low insulin and high glucocorticoid levels induce the gluconeogenic flux. The metabolic actions of these hormones are mediated by modulation of the activities of key regulatory glycolytic and gluconeogenic enzymes ; one of these is 6-phosphofructo-2-kinase\fructose-2,6-bisphosphatase (PF2K\Fru-2,6-BPase ; EC 2.7.1.105\3. 1.3.46) . This is a bifunctional enzyme that catalyses both the synthesis and the degradation of fructose-2,6-bisphosphate [Fru(2,6)P # ], a potent stimulator of 6-phosphofructo-1-kinase and inhibitor of fructose 1,6-bisphosphatase. PF2K\Fru-2,6-BPase can be considered to be either a glycolytic or a gluconeogenic enzyme ; it acts as a switch between glycolysis and gluconeogenesis in mammalian liver by regulating the level of Fru(2,6)P # [1] . Different PF2K\Fru-2,6-BPase isoenzymes have been described depending on the tissue and cell specificity. Hepatic PF2K\Fru-2,6-BPase is subjected to a complex pattern of hormonal regulation in which insulin exerts an opposite transcriptional effect depending on the hormonal context. Insulin weakly stimulates transcription from the L-type PF2K\Fru-2,6-BPase promoter Abbreviations used : CAT, chloramphenicol acetyltransferase ; DMEM, Dulbecco's modified Eagle's medium ; ERK, extracellular signal-regulated protein kinase ; FCS, fetal calf serum ; Fru(2,6)P 2 , fructose-2,6-bisphosphate ; GSK-3, glycogen synthase kinase 3 ; JNK, c-Jun-N-terminal kinase ; JBD, JNK-binding domain ; JIP-1, JNK-interacting protein 1 ; JNK-SAPK, MEK-4-stress-activated protein kinase-c-Jun-N-terminal protein kinase ; MAP kinase, mitogen-activated protein kinase ; MEK, MAP kinase/ERK kinase ; p70 S6 kinase, p70/p85 ribosomal S6 kinase ; PEPCK, phosphoenolpyruvate carboxykinase ; PF2K/Fru-2,6-BPase, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase ; PI-3K, phosphoinositide 3-kinase. 1 To whom correspondence should be addressed (e-mail tauler!farmacia.far.ub.es).
binding domain of the JNK-interacting protein 1 (' JIP-1 '), demonstrating that activation of JNK is necessary for the insulin inhibitory effect. Moreover, overexpression of MEK kinase 1 and JNK-haemagglutinin resulted in the inhibition of the glucocorticoid-stimulated PF2K\Fru-2,6-BPase. These results provide clear and specific evidence for the role of JNK in the insulin inhibition of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression. In addition, we performed experiments with a mutant of the glucocorticoid receptor in which the JNK phosphorylation target Ser-246 had been mutated to Ala. Our results demonstrate that the phosphorylation of the glucocorticoid receptor on Ser-246 is not responsible for the JNK repression of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression.
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when used alone [2, 3] ; in contrast, in the presence of glucocorticoids, insulin inhibits the glucocorticoid-induced stimulation of PF2K\Fru-2,6-BPase gene expression [4, 5] . This pattern of hormonal regulation resembles that of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) [6, 7] . However, changes in the phosphorylation state of the enzyme induced by insulin need to be considered for an understanding of the effect of this hormone on the activity of the bifunctional enzyme. Insulin regulates the expression of several genes through the activation of distinct signalling pathways [8] . There is evidence for a direct role of mitogen-activated protein (MAP) kinase cascades in the regulation of expression of certain immediate early genes such as c-fos [9] . Insulin might mediate its mitogenic effects via this pathway. In contrast, phosphoinositide 3-kinase (PI-3K) is a major conduit for the signals that regulate the metabolic responses to insulin [10] . In adipocytes, PI-3K inhibitors such as wortmannin and LY 294002 have been used to indicate the importance of this pathway in GLUT 4 translocation to the surface membrane [11] and system A amino acid transport [12] . The effects of insulin on glycogen synthase kinase 3 (GSK-3) [13, 14] , PEPCK [15, 16] , glucose-6-phosphatase [17] and gene 33 [18] are also blocked by inhibiting PI-3K activity. The activation of p70\p85 ribosomal S6 kinase (p70 S6 kinase) was not involved in the regulation of these genes by insulin. However, a PI-3K\p70 S6 kinase-dependent pathway is required for the regulation of glucose-6-phosphate dehydrogenase [19] and hexokinase II [20] by insulin.
Recently, several studies have been conducted to explain the molecular mechanism involved in the insulin repression of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression [21] . Although this previous work seems to eliminate the involvement of the PI-3K and ERK1\2 cascades, nothing is known about the transductional pathway responsible for this effect.
Our results show clearly that the MEK-4-stress-activated protein kinase-c-Jun-N-terminal protein kinase (JNK-SAPK) pathway is responsible for mediating the insulin repression of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression. We further demonstrate that this effect is independent from the phosphorylation of the glucocorticoid receptor on Ser-246. Tissue culture H4IIE cells and CV1 cells were routinely grown in DMEM supplemented with 10 % (v\v) FCS, 100 i.u.\ml penicillin and 100 µg\ml streptomycin at 37 mC in humidified air\CO # (19 : 1). Cells were serum-starved overnight and treated with hormones and chemical inhibitors for the durations and in the concentrations indicated in the figure legends. The inhibitors were added 30 min before the hormones. Because the inhibitors used were dissolved in DMSO, an equal amount of DMSO carrier was added to the cells with all treatments described here.
EXPERIMENTAL

Plasmid constructs
The reporter gene construct L-pBLCAT (in which CAT stands for chloramphenicol acetyltransferase) containing a 500 bp HinfI-HinfI 5h flanking region of the L isoform of PF2K\Fru-2,6-BPase cloned into a pBLCAT3 plasmid was provided by Dr A. J. Lange (University of Minnesota, Minneapolis, MN, U.S.A.) [22] . Plasmids coding for the JNK-binding domain (JBD) of JIP-1 and GAL 4-luciferase were provided by Dr R. J. Davis (University of Massachusetts, Worcester, MA, U.S.A.) [23] and GAL 4-ATF-2 was provided by Dr N. Jones (Imperial Cancer Research Fundation, London, U.K.) [24] . Expression vectors coding for the MEK kinase (MEKK)-1 protein and the epitopetagged JNK-haemagglutinin (JNK-HA) were provided by Dr C. Caelles (Universitat de Barcelona, Barcelona, Spain) ; the wildtype glucocorticoid receptor and the S246A glucocorticoid receptor mutant were provided by Dr J. M. Garabedian (University of New York, New York, U.S.A.) [25] ; and pPCK10 plasmid coding for the PEPCK was provided by Dr R. W. Hanson (Case Western Reserve University, Cleveland, OH, U.S.A.) [26] .
Total RNA extraction
Total cellular RNA was extracted by the LiCl\urea method [27] . The RNA was dissolved in sterile water ; the concentration and purity of each sample were assessed by A #'! and by the ratio of A #'! to A #)! respectively. The abundance of PF2K\Fru-2,6-BPase mRNA was measured by Northern blot analysis with standard procedures [28] . The following probes were used : a 1 Kb EcoRI fragment isolated from the pKBplasmid [29] to detect PF2K\Fru-2,6-BPase abundance and a 2.6 kb Pst-1 fragment isolated from the pPCK10 plasmid [26] for PEPCK. The integrity of the RNA was verified by observing the rRNA bands in the ethidium bromide gel under UV irradiation. The levels of mRNA were evaluated by densitometric scanning of the autoradiogram and corrected by the amount of 18 S rRNA with the use of a ribosomic cDNA probe [30] .
Transfection and CAT assay
CsCl double-gradient centrifugation was used to prepare all plasmids for transfections. H4IIE cells and CV1 cells were transfected with the different combinations of the indicated plasmids with 30 µg DNA per 100 mm tissue culture dish by the calcium phosphate method [31, 32] . After transfection, cells were harvested by tryptic digestion, split into 60 mm tissue culture dishes and then incubated in DMEM supplemented with 10 % (v\v) FCS for 24 h. Cells were further washed and incubated in serum-free DMEM for 12 h and placed in serum-free DMEM containing the agents indicated in the figure legends for 12 h. Cell extracts were prepared and assayed for CAT [28] , luciferase and Renilla activities (in accordance with the manufacturers' instructions). The values were normalized by the amount of protein measured by the Bio-Rad method. The statistical significance of the differences was assessed by Student's unpaired test with STATVIEW II TM software for Apple Macintosh computers.
Kinase assays
Cells were harvested in 500 µl of cell lysis buffer [20 mM Hepes (pH 7.5)\1 % (v\v) Nonidet P40\10 mM EGTA\2.5 mM MgCl # \40 mM β-glycerol phosphate\2 mM sodium vanadate\1 mM dithiothreitol\1 mM PMSF\1 µg\ml aprotinin\1 µg\ml leupeptin], kept on ice for 30 min and centrifuged at 6000 g for 10 min at 4 mC. For endogenous ERK activity, the resulting supernatants were incubated for 1 h at 4 mC with 40 µl of anti-(ERK)-Protein A-Sepharose beads. For transfected JNK-HA activity, the resulting supernatants were incubated for 2 h at 4 mC with 40 µl of anti-(HA)-Protein G-Sepharose beads. The beads were washed three times in ice-cold PBS in the presence of 0.1 % (v\v) Nonidet P40 and 2 mM Na $ VO % and once in kinase buffer [12.5 mM MOPS (pH 7.5)\12.5 mM β-glycerol phosphate\ 7.5 mM MgCl # \0.5 mM EGTA\0.5 mM NaF\0.5 mM Na $ VO % \1 mM dithiothreitol] resuspended in 30 µl of the kinase buffer ; the kinase reaction was initiated by adding the substrates (40 µg of myelin basic protein for ERK activity and 1 µg of glutathione S-transferase-c-Jun for JNK activity) along with 20 µM ATP and 100 µCi of [γ-$#P]ATP. The reaction proceeded for 30 min at 37 mC and was terminated by the addition of 15 µl of 4iLaemmli buffer. Samples were subjected to SDS\PAGE [12 % (w\v) gel] ; results were quantified by autoradiography.
RESULTS AND DISCUSSION
The molecular pathways leading to the insulin repression of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression were studied in H4IIE rat hepatoma cells. This cell line was chosen because much information is available on PF2K\Fru-2,6-BPase regulation and the insulin signal transduction pathway. It has been reported that insulin activates the PI-3K pathway in H4IIE cells [15] . To assess the role of PI-3K in the insulin repression of glucocorticoid-stimulated PF2K\Fru-2,6-BPase mRNA levels, we determined the effects of LY 294002, the highly specific inhibitor of the p110 catalytic subunit of PI-3K [33] . Treatment of H4IIE cells with insulin for 3 h decreased PF2K\ Fru-2,6-BPase mRNA levels by 50 %. The addition of LY 294002 did not block this repression ( Figure 1A ). In addition, we analysed the content of PEPCK mRNA to ensure that LY 
Figure 4 Effect of PD 098059 on the insulin repression of glucocorticoidstimulated PF2K/Fru-2,6-BPase mRNA
(A) H4IIE cells deprived of serum for 24 h were preincubated with the indicated PD 098059 concentrations for 10 min before the addition of 1 µM dexamethasone and 100 nM insulin for 15 min. Cell extracts were obtained and ERK activity was measured by 32 P incorporation into myelin basic protein (MBP) as described in the Experimental section. (B) H4IIE cells deprived of serum for 24 h were preincubated with the indicated PD 098059 concentrations for 10 min before the addition of 1 µM dexamethasone and 100 nM insulin, as indicated, for 3 h and then processed as described in the legend to Figure 1 . Values are expressed relative to those for cells treated with dexamethasone and 50 µM PD 098059, which was taken as 100 arbitrary units. Results are meanspS.E.M. for three independent experiments. Upper panel : a representative Northern blot.
294002 inhibited the PI-3K pathway under our experimental conditions. Previous reports have demonstrated that PEPCK gene expression is inhibited by insulin through the PI 3-K pathway [15, 34] . As expected, LY 294002 blocked the inhibitory effect of insulin on glucocorticoid-stimulated PEPCK gene expression ( Figure 1B) . Indeed, LY 294002, both in the absence and in the presence of insulin, produced concentration-dependent decreases in glucocorticoid-stimulated PF2K\Fru-2,6-BPase mRNA levels. The finding that inhibition of PI 3-K represses the stimulatory action of glucocorticoids on PF2K\Fru-2,6-BPase expression clearly indicates that activation of PI 3-K is not required for insulin to inhibit the stimulation of PF2K\Fru-2,6-BPase gene expression by glucocorticoids. Very recently it has been reported that rat glucocorticoid receptor is phosphorylated by GSK-3 in itro and in cultured mammalian cells. This phosphorylation inhibits the transcriptional enhancement of the glucocorticoid receptor [35] . GSK-3 is one of the final targets of the PI-3K pathway, so the inhibition of the glucocorticoid stimulatory effect on PF2K\Fru-2,6-BPase mRNA levels caused by LY 294002 could be due to a phosphorylation of the glucocorticoid receptor by GSK-3. To determine further whether the regulation of PF2K\Fru-2,6-BPase mRNA levels described above was due to a regulation of its transcriptional rate, H4IIE cells were transiently transfected with the reporter gene construct L-pBLCAT, a CAT reporter gene under the transcriptional control of the L-type PF2K\Fru-2,6-BPase promoter. The results of the CAT analysis show that LY 294002 was not able to revert the insulin inhibition of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression (Figure 2) . These results strongly suggest the independence of the PI-3K pathway in insulinmediated repression.
To test further the involvement of p70 S6 kinase, we analysed the effect of rapamycin on the insulin inhibition of glucocorticoidstimulated PF2K\Fru-2,6-BPase mRNA levels. Rapamycin blocks the stimulation of p70 S6 kinase activity by insulin in a variety of cell types, without affecting PI-3K activity [36, 37] . The addition of rapamycin did not block the ability of insulin to repress the stimulatory effect of glucocorticoids (Figure 3) . The same results were found at the transcriptional level (Figure 2 ).
A
Figure 6 Effect of the overexpression of MEKK-1, JNK-HA and wild-type or S246A glucocorticoid receptor on glucocorticoid-stimulated PF2K/Fru-2,6-BPase gene expression
(A) CV1 cells were transfected as described in the Experimental section with the indicated concentrations of the plasmid coding for MEKK-1 and 2.5 µg of the plasmid coding for JNK-HA, serum-starved for 24 h and treated with 1 µM dexamethasone for 15 min. Cell immunoprecipitates were obtained and JNK activity was measured by 32 P incorporation into glutathione S-transferase-c-Jun (1-233) as described in the Experimental section. (B) CV1 cells were transfected as described in the Experimental section with the indicated concentrations of the plasmid coding for MEKK-1, 2.5 µg of JNK-HA and 5 µg of the wild-type (wt) glucocorticoid receptor (GR), then treated with 1 µM dexamethasone for 12 h. Cell extracts were assayed for CAT activity and values are expressed relative to that for cells treated with dexamethasone in the absence of MEKK-1 overexpression, which was taken as 100. Results are meanspS.E.M. for three independent experiments. Statistical significances : *P 0.05, **P 0.01 in comparison with dexamethasone-treated cells. (C) CV1 cells were transfected as described in the Experimental section with the indicated concentrations of the plasmid coding for MEKK-1, 2.5 µg of JNK-HA and 5 µg of the plasmid coding for the mutant S246A GR and treated with 1 µM dexamethasone for 12 h. Cell extracts were assayed for CAT activity and values are expressed relative to that for cells treated with dexamethasone in the absence of MEKK-1 overexpression, which was taken as 100. Results are meanspS.E.M. for eight independent experiments. Statistical significance : ***P 0.001 in comparison with dexamethasone-treated cells.
Thus our experiments indicate that p70 S6 kinase is not required for the insulin-mediated inhibition of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression.
Multiple members of the MAP kinase family are activated in response to insulin, including ERK1\2, p38 and JNK [38] [39] [40] [41] [42] . To evaluate the relative importance of these kinases on the inhibitory effect of insulin on glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression, we determined the effect of several specific inhibitors on this regulation. PD 098059 was used to determine the role of ERK1\2. This compound is a noncompetitive inhibitor of MEK that blocks the activation of MEK by Raf-1 [43] . Northern blot analyses of cells show that insulin inhibits glucocorticoid-induced PF2K\Fru-2,6-BPase mRNA levels. When cells were pretreated with PD 098059, this inhibitor did not totally prevent the effect of insulin on PF2K\Fru-2,6-BPase mRNA levels ; however, a small increase was observed in a dose-dependent manner ( Figure 4B ). The finding that PD 098059 increases PF2K\Fru-2,6-BPase mRNA levels in cells treated with dexamethasone, both in the presence and in the absence of insulin, indicates that the target of ERK1\2 regulation is the glucocorticoid receptor. The inhibitory effect of MAP kinase on the glucocorticoid receptor has been previously reported, although no direct phosphorylation of the glucocorticoid receptor by ERK1\2 has been found [44] . These results suggest the independence of the ERK1\2 pathway in the mediation of insulin repression of glucocorticoid-induced PF2K\ Fru-2,6-BPase mRNA levels. Additionally, we performed a kinase assay in itro to ensure that ERK1\2 was inactivated in the presence of PD 098059 under our experimental conditions ( Figure 4A ). To determine further whether the regulation of PF2K\Fru-2,6-BPase mRNA levels was due to a regulation of its transcriptional rate, H4IIE cells were transiently transfected with the reporter gene construct L-pBLCAT. The transcriptional analysis shows that the use of PD 098059 did not prevent the insulin inhibitory effect (Figure 2 ). These results show that the ERK1\2 cascade is not involved in the insulin repression of glucocorticoids in the regulation of the L-type PF2K\Fru-2,6-BPase.
The activation of p38 MAP kinase is induced by insulin in H4IIE cells [45] . We used the highly specific inhibitor of the p38 MAP kinase, SB 203580 [46] , to determine whether this member of the MAP kinase family could be responsible for the effect of insulin on PF2K\Fru-2,6-BPase gene expression. The addition of this chemical inhibitor did not cause any significant change on mRNA levels (results not shown). The transcriptional analysis with SB 203580 did not modify the repressive effect of insulin ( Figure 2 ). These results show that at least the α and β isoforms of the p38 family of MAP kinase do not seem to have an effect on the regulation of glucocorticoid-stimulated PF2K\Fru-2,6-BPase by insulin.
No specific chemical inhibitors are available for the JNK. However, the N-terminal JBD of the cytoplasmic protein JIP-1 has been recently described to cause a cytoplasmic retention of JNK, an inhibition of JNK-regulated gene expression and a suppression of the effects of the JNK signalling pathway [23] . JBD of JIP-1 competes with c-Jun and ATF-2, targets of the JNK signal transduction pathway, for interaction with JNK, leading to inhibition of the JNK signal transduction pathway. To study the involvement of JNK in insulin repression, the JBD of JIP-1 was co-transfected with the reporter gene construct LpBLCAT and the transcriptional activity was analysed in the presence or absence of insulin and dexamethasone. In the absence of the JBD of JIP-1, insulin inhibits the stimulatory effect of dexamethasone on PF2K\Fru-2,6-BPase gene expression ; however, the presence of the JBD of JIP-1 completely blocks this effect ( Figure 5A) . To ensure the endogenous activation of JNK by insulin and its complete inhibition by the JBD of JIP-1, we additionally co-transfected a reporter system based on two plasmids, the first encoding the GAL 4-ATF-2 fusion gene and the second encoding the luciferase reporter gene under the control of a promoter with a GAL 4 DNA-binding domain. In the presence of insulin, JNK was endogenously activated and thus we obtained a large increase in luciferase activity. In contrast, in the presence of the JBD of JIP-1, luciferase activity was repressed in a manner dependent on dose concentration ( Figure  5B ). These results demonstrate that JNK is responsible for the insulin-mediated repression of glucocorticoid-stimulated L-type PF2K\Fru-2,6-BPase gene expression.
To identify the molecular mechanism for insulin-induced JNK inhibition of glucocorticoids in the regulation of PF2K\Fru-2,6-BPase gene expression, we performed a number of experiments with the CV1 cell line as a model of cells that do not express the glucocorticoid receptor endogenously and in which the L-type PF2K\Fru-2,6-BPase is efficiently expressed. To obtain evidence that activation of the JNK enzymic activity itself was responsible for insulin repression, we overexpressed MEKK-1 (a kinase believed to be further upstream in the JNK-SAPK signalling pathway and responsible for its activation in transfected cells [47] ), JNK with a HA-tagged epitope and the wild-type glucocorticoid receptor. Our results show that overexpression of MEKK-1 and JNK-HA in CV1 cells ectopically expressing the wild-type glucocorticoid receptor totally inhibited glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression ( Figure 6B ). We performed a JNK assay in itro to ensure the activation of transfected JNK-HA by MEKK-1 ( Figure 6A ). These results provide strong evidence for the direct role of JNK in the inhibition of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression.
The glucocorticoid receptor is phosphorylated at four major sites (Thr-171, Ser-224, Ser-232 and Ser-246) in its N-terminal transcriptional regulatory region [44] . It has recently been reported that JNK inhibits glucocorticoid receptor transcriptional activation by direct receptor phosphorylation at Ser-246 [25] . To determine whether JNK regulation was due to phosphorylation of the glucocorticoid receptor, we performed experiments with a mutant of the glucocorticoid receptor in which Ser-246 had been mutated to Ala, consequently losing its responsiveness to JNK-mediated phosphorylation. In these experiments we endogenously activated JNK by co-transfecting MEKK-1. JNK activation in cells expressing the mutant S246A glucocorticoid receptor resulted in the inhibition of the glucocorticoid-induced PF2K\Fru-2,6-BPase gene expression in the same way as when the wild-type glucocorticoid receptor was used ( Figure 6C ). These results demonstrate that JNK mediates the insulin inhibition of glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression through a mechanism independent of phosphorylation at Ser-246 in the glucocorticoid receptor. These findings provide evidence for a novel mechanism of JNK inhibition of glucocorticoid-stimulated gene expression independent of direct phosphorylation of the glucocorticoid receptor on Ser-246.
Insulin inhibition of glucocorticoid-activated gene expression is a common phenomenon in the regulation of gluconeogenic enzymes. It has been stated that insulin inhibits glucocorticoidinduced PEPCK and glucose-6-phosphatase gene expression through the PI-3K pathway independently of p70 S6 kinase [15, 17] . Our results demonstrate that the signalling pathway responsible for the effects of insulin relative to the inhibition of the glucocorticoid-stimulated PF2K\Fru-2,6-BPase gene expression is the JNK-SAPK pathway.
